The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10
2016 ◽
Vol 35
◽
pp. 174-184
◽
Keyword(s):
T Cell
◽